PartnerTech and Phadia extend cooperation

PartnerTech and Phadia extend cooperation 

PartnerTech and Phadia - which is a world leader in systems for diagnosing and
monitoring allergy, asthma and autoimmune diseases - have extended their
cooperation and signed a long-term agreement. The agreement, which covers
production of the ImmunoCAP 100 instrument and spare parts until 2012, has an
estimated value of SEK 20 million per year. "PartnerTech offers the level of expertise and quality that we need in a
contract manufacturer," says Phadia purchasing manager Mikael Pauhlson. "Our
joint effort to develop the ImmunoCAP 100 instrument included many measures that
led to a more competitive product. That's why we decided to take the next step
and sign a long-term cooperative agreement."

ImmunoCAP is an integrated system for precise testing, automated laboratory
instruments and leading-edge information technology. The system is user-friendly
and generates reliable results. A simple blood test enables identification and
monitoring of patients with asthma and allergies. The agreement covers
production of the ImmunoCAP 100 instrument and spare parts. Phadia is served by
PartnerTech's Åtvidaberg customer center, where production of the instrument and
spare parts is already under way. "We have worked closely with Phadia for a long time and are pleased that the
cooperation is being extended,” says acting PartnerTech CEO Rune Glavare.
“PartnerTech has solid and strong competence in biomedical equipment
manufacturing.”




For additional information, please call: 
Rune Glavare, Acting CEO, PartnerTech AB, +46 (0) 706 20 24 54
Mikael Pauhlson, Purchasing Manager, Phadia, +46 (0)18 16 37 58


Phadia
Phadia is a world-leading developer, manufacturer and marketer of blood test
systems to support the clinical diagnosis and monitoring of allergy, asthma and
autoimmune diseases. The company is headquartered in Uppsala, where research,
development and production in the area of allergy diagnosis is conducted. All
development and production in the field of autoimmune diseases takes place in
Freiburg, Germany. More than 3,000 laboratories in 60 countries use Phadia's
products. See www.phadia.com

PartnerTech
PartnerTech develops and manufactures products under contract for leading
companies, primarily in telecommunications, IT, the engineering industry and
medical technology. With some 1,800 employees at its plants in Sweden, Norway,
Finland, Poland, the UK, the United States and China, PartnerTech reported sales
of approximately SEK 3 billion in 2006. PartnerTech AB (www.partnertech.com),
the parent company, is headquartered in Malmö and listed on the OMX Nordic
Exchange Stockholm.  

Information reported to the Swedish Financial Supervisory Authority
(Finansinspektionen)